Corvus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference

NEXT STORY
Vystar Acquires Fluid Energy Conversion Technology Assets, Expands Reach Into New Vertical Markets 
PREV STORY
Treos Bio Announces Positive Interim Results from a Phase 1/2 Clinical Trial of Precision Cancer Vaccine Plus Maintenance Therapy in Patients with Metastatic Colorectal Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chembio Diagnostics Provides Update on Regulatory Status of DPP HIV-Syphilis System

author_avatar
NASDAQ Market News

Lumos Pharma Appoints Joseph S. McCracken, DVM, MS to Board of Directors Rick Hawkins, CEO, appointed Chairman of the Board

author_avatar
NASDAQ Market News

Lexicon Pharmaceuticals Announces Preclinical Efficacy Data on Telotristat Ethyl’s Antiproliferative Effects Against Various Cancer Cell Lines

author_avatar
NASDAQ Market News